$SMCI

Super Micro jumps premarket on outlook boost, H&R Block surges

U.S. stock futures edged higher ahead of CPI, with investors watching for signals on the Fed’s rate path. In premarket movers, Super Micro Computer rose over 9% on full-year guidance above expectations. H&R Block gained 13.9% after Q4 adjusted EPS of $2.38 vs $2.31 consensus, revenue $3.95B, and FY27 EPS outlook $6.04-$6.24. Other movers included Owlet, Valens Semiconductor, and Riskified.

Original reporting
Published Aug 12, 2026, 11:41 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 12:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$SMCI
Bullish
medium confidence
Mentioned
$SMCI · $HRB · $OWLT · $VLN · $RSKD · $ANNX
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$SMCIBullishHigh
01

Why it matters

These are same-day, company-specific catalysts that can drive immediate repricing at the open, especially where the article cites guidance or endpoint changes versus consensus.

02

Market read

Company-specific earnings, guidance, and trial design updates are the dominant drivers of premarket moves, while CPI is the macro overhang for rate-sensitive tech.

03

What to watch

The article does not include full guidance detail, margin commentary, or management commentary; for Annexon, the market may be over-weighting month-15 signal clarity versus the added month-24 endpoint flexibility.

Relevance 8/10Novelty 8/10Timing: pre-market today, ahead of the open after guidance, earnings, and trial updates

Background

The piece frames the session around looming US CPI and highlights multiple premarket movers driven by earnings, guidance, and a clinical-trial amendment.

Company-level read

Ticker impact

$SMCIBullishMedium confidence
Context

Super Micro Computer rallied more than 9% premarket after issuing full-year guidance well above Wall Street expectations.

Expected impact

Likely continued upside bias at the open, with volatility elevated until the market digests guidance details.

Evidence & confidence

The article cites a same-day guidance surprise versus consensus, which typically drives immediate repricing and follow-through risk.

$HRBBullishHigh confidence
Context

H&R Block shares surged 13.9% premarket after better-than-expected Q4 earnings and a stronger-than-anticipated outlook.

Expected impact

Higher open likely, but expect profit-taking risk given the large premarket move.

Evidence & confidence

The text provides specific EPS and revenue beats plus a FY2027 adjusted EPS forecast range above prior expectations.

$OWLTBullishMedium confidence
Context

Owlet stock jumped nearly 10% premarket after reporting record Q2 results with revenue up 29.9% and a much smaller adjusted loss.

Expected impact

Potential continuation early, but follow-through depends on whether investors focus on margin trajectory and guidance not provided here.

Evidence & confidence

The article includes concrete Q2 growth and loss narrowing figures, supporting a valuation reset narrative.

$VLNBullishMedium confidence
Context

Valens Semiconductor climbed 14.9% after reporting Q2 revenue of $18.1 million and raising full-year revenue outlook.

Expected impact

Upside bias at the open, with sensitivity to how much the raised outlook exceeds consensus.

Evidence & confidence

The article notes the company’s own guidance was exceeded and the full-year outlook was raised, which is typically supportive for near-term trading.

$RSKDBullishMedium confidence
Context

Riskified shares rose 15.8% premarket after reporting Q2 revenue up 22% year-over-year, the strongest growth in over four years.

Expected impact

Likely strong open and volatility, with traders watching for any commentary on fraud-prevention platform scaling.

Evidence & confidence

The article provides a clear growth acceleration versus consensus and includes free cash flow, supporting a bullish read-through.

$ANNXBearishMedium confidence
Context

Annexon shares fell 5.9% premarket after amending its Phase 3 ARCHER II trial endpoints for vonaprument.

Expected impact

Downward pressure likely at the open, with continued volatility until investors assess implications for topline timing.

Evidence & confidence

The article explicitly links the amendment to investor concerns about the month-15 efficacy signal, a direct sentiment driver.

Market effects

AI infrastructure and fraud-prevention software names show strong premarket repricing tied to guidance and growth acceleration; biotech sentiment is sensitive to trial endpoint design.

Primarily US single-stock moves; futures are slightly higher ahead of CPI, so stock-specific catalysts dominate.

Limited direct global linkage beyond broad AI and semiconductor demand narratives.

Counterpoint

Large premarket gaps can reverse if investors interpret guidance beats as one-off or if details (margins, backlog, or trial read-through) disappoint on the call.

Key entities

  • Super Micro Computer

    AI server maker with full-year guidance above expectations, triggering a premarket rally.

  • H&R Block

    Tax preparation firm with Q4 EPS and FY2027 outlook above consensus, lifting shares premarket.

  • Owlet

    Digital parenting platform with record Q2 results and narrowed adjusted loss.

  • Valens Semiconductor

    Chipmaker with Q2 revenue and raised full-year outlook.

  • Riskified

    E-commerce fraud prevention company with accelerated revenue growth and strong premarket move.

Related articles

$ANNXMed

Annexon Advances C1q-Targeted Therapies; Tanruprubart BLA Filing And ARCHER II Data On The Horizon

Annexon Biosciences (ANNX) reported Q2 2026 results and clinical updates. It said Phase 3 FORWARD tanruprubart in Guillain-Barre has treated the first 10 U.S. and European patients and expects a Q4 2026 BLA filing. For vonaprument in geographic atrophy, ARCHER II remains on track with Month 15 data in Q4 2026 and final completion in Q3 2027. Q2 R&D was $46.6M, net loss $55.3M. Cash was $209.2M. A $200M credit facility was arranged with $50M drawn.

$SMCIMed

SMCI Stock Eyes 1-Month High As Analysts Lift Targets After Earnings, But Caution AI Server Margins 'Not Sustainable'

Super Micro Computer (SMCI) rose in premarket after earnings as analysts raised price targets but warned double-digit AI server margins may not be sustainable. Bank of America lifted its target to $33 from $28 (Underperform), citing strong revenue growth but margin pressure from competition, costs, and investments. Goldman raised to $34 (Sell), Citi to $39 (Neutral), and Barclays to $39 (Equal Weight).

$RSKDHighAI 9/10

Why is Riskified stock surging today?

Riskified (RSKD) shares rose about 15.8% in pre-open after the company reported Q2 2026 revenue of $98.7 million, up 22% year over year and above the $89.2 million consensus. Adjusted EPS was $0.02. Free cash flow was $12.9 million. Riskified raised full-year 2026 revenue guidance to $400–$410 million (midpoint $405 million).

$VLNHighAI 9/10

Why is Valens Semiconductor stock soaring today?

Valens Semiconductor shares rose about 14.9% in pre-open trading after the company reported Q2 2026 results and raised full-year revenue guidance. Valens said Q2 revenue was $18.1M, above its $17.2M-$17.6M range, and lifted 2026 guidance to $78.0M-$81.0M. It also guided Q3 revenue of $21.3M-$21.7M.